Columbia researchers found that a gene associated with an autoimmune form of hair loss could be activated to improve cancer immunotherapy.
Seventy-five percent of patients with an autoimmune disease that causes hair loss had significant hair regrowth after treatment with ruxolitinib.
Interdisciplinary dermatology research is helping advance understanding of conditions like alopecia areata, epidermolysis bullosa, and skin cancer.
Articles about hair regeneration, cocoa and memory, and flu forecasting are among the most-viewed research stories on CUMC websites.
Columbia researchers identify immune cells responsible for destroying hair follicles in people with alopecia areata and restore hair growth with an FDA-approved drug
During a U.S. News Twitter chat on #SunHealth, Dr. Larisa Geskin offered expert advice on sunscreen, sunglasses, and more.